Is Edesa Biotech Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: EDSA) stock is to Buy EDSA stock.
Out of 1 analyst, 0 (0%) are recommending EDSA as a Strong Buy, 1 (100%) are recommending EDSA as a Buy, 0 (0%) are recommending EDSA as a Hold, 0 (0%) are recommending EDSA as a Sell, and 0 (0%) are recommending EDSA as a Strong Sell.
What is EDSA's revenue growth forecast for 2024-2024?
(NASDAQ: EDSA) Edesa Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Edesa Biotech's revenue in 2024 is $0.
In 2024, EDSA is forecast to generate $14,272,920 in revenue, with the lowest revenue forecast at $14,272,920 and the highest revenue forecast at $14,272,920.
What is EDSA's forecast return on assets (ROA) for 2024-2027?
(NASDAQ: EDSA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
What is EDSA's Price Target?
According to 1 Wall Street analyst that have issued a 1 year EDSA price target, the average EDSA price target is $21.00, with the highest EDSA stock price forecast at $21.00 and the lowest EDSA stock price forecast at $21.00.
The Wall Street analyst predicted that Edesa Biotech's share price could reach $21.00 by Feb 14, 2025. The average Edesa Biotech stock price prediction forecasts a potential upside of 387.24% from the current EDSA share price of $4.31.
What is EDSA's forecast return on equity (ROE) for 2024-2027?
(NASDAQ: EDSA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.